Vascular Surgery for Arteriovenous Malformations Treatment & Management

Updated: Sep 09, 2016
  • Author: Allison Leigh Speer, MD; Chief Editor: Vincent Lopez Rowe, MD  more...
  • Print
Treatment

Medical Care

The mainstays of arteriovenous malformation (AVM) management are not medical; rather, they involve interventional radiology procedures and surgery such as embolization, sclerotherapy, surgical resection, and reconstruction. [5, 1, 9]

Embolization/sclerosing agents

Absolute to 80% ethanol, N-butyl cyanoacrylate (NBCA) glue, various types of coils, and/or contour particles such as Ivalon can be used in various combinations, simultaneously or in stages, as primary or adjunctive embolization/sclerosing agents, depending upon the location, severity, and extent of the AVM.

Ethanol is usually contraindicated and NBCA relatively contraindicated for high-flow fistulous lesions because of the high risk of early wash into the systemic circulation. These fistulous AVMs can generally be treated through a staged approach. Coil embolization is used as a preliminary procedure to slow down the flow, resulting in decreased risk of subsequent distal thromboembolism. Then, agents such as ethanol or NBCA glue can be used to definitively treat the lesion.

Absolute to 80% ethanol can be given via transarterial, transvenous, or direct puncture injection. Ethanol injection has a high complication rate but results in fewest recurrences when used as a primary treatment for surgically inaccessible lesions. Major complications include deep vein thrombosis, transient nerve palsy, and ear cartilage necrosis. Minor complications are mainly skin changes. [21]

NBCA glue is predominately used for surgically excisable lesions as preoperative embolization therapy to reduce blood loss intraoperatively. It is not typically used as a permanent sclerosing agent because convincing evidence that it induces permanent damage to endothelial cells is lacking. Pulmonary embolism is rare but can occur. [21]

Next:

Surgical Care

Treatment is rare during infancy and early childhood for stage I AVM. Stage I AVMs can be followed with yearly examinations. Infrequently and after careful consideration, resection may be performed for a well-localized quiescent stage I AVM (ie, when complete resection is possible without poor cosmesis; however, this remains controversial).

Usually, invasive treatment is delayed until local endangering signs (stage III) are present or cardiac complications (stage IV) develop. In the uncommon occurrence of congestive heart failure caused by an AVM, prompt embolization may be necessary.

As mentioned previously, proximal embolization of feeding arterial vessels should never be performed, because this leads to rapid recruitment of new vessels from adjacent arteries to supply the nidus, with growth and progression of the lesion. Similarly, partial surgical excision leads to only temporary improvement, followed by reexpansion of the AVM over time.

Management of AVMs is challenging because selecting the optimal therapy to minimize recurrence is often difficult. Sometimes, complete resection is not possible or would result in severe disfigurement, as in the case of diffuse or infiltrating AVMs that invade pelvic tissues, permeate deep craniofacial structures, or penetrate all tissue planes of an extremity. In these cases, embolization or sclerotherapy is indicated and may be successful.

Generally, the treatment of AVMs is either palliative to control a complication (intractable pain, skin ulceration, tissue necrosis, bleeding, or lytic bone lesion with risk of fracture) or aims to be curative (embolization followed by wide surgical resection and reconstruction). [5, 1] Indications for surgery are listed in Table 4 below.

Table 4. Indications for Surgical Treatment of AVMs (Open Table in a new window)

Absolute Indications Relative Indications
Hemorrhage



Ischemia (arterial insufficiency or ulceration, gangrene)



Chronic venous insufficiency with venous hypertension



Lesions that compromise breathing, vision, hearing, or eating



High-output cardiac failure



Poor quality of life (disabling or intractable pain, functional impairment, severe cosmetic deformity)



Lesions with potentially high risk of complications (eg, hemarthrosis, fracture, or limb-threatening location)



Vascular-bone syndrome with limb length discrepancy



Table modified from Lee et al. [21]

Preoperative surgical planning should involve a thorough review of results from magnetic resonance imaging (MRI), magnetic resonance angiography (MRA), or angiography. Surgical resection is usually preceded by arterial embolization for temporary nidus occlusion. This minimizes intraoperative bleeding but does not reduce the limits of planned resection. Both the AVM nidus and the involved skin must be excised widely, though if the overlying skin appears normal, it can be saved. (See the image below.)

Left thigh arteriovenous malformation (AVM). Panel Left thigh arteriovenous malformation (AVM). Panel A: intraoperative. Panel B: bisected.

To minimize recurrence, the goal of surgery for an AVM is complete resection, in contrast to the staged resection applicable to slow-flow vascular malformations. The best wound coverage is primary closure with local or distant tissue flaps. Amputation is a viable option for the ischemic or nonfunctional extremity. Combined embolization and surgical resection is most successful for well-localized stage I/II AVMs. However, these patients must still be followed for years.

In one series, all 16 patients with surgically accessible, localized, noninfiltrating AVMs who underwent preoperative angioembolization with subsequent surgical excision demonstrated no evidence of recurrence on angiography during a follow-up averaging 24.3 months. [21]

A computed tomography (CT)-guided frameless robotic radiosurgical approach to intracranial AVMs has been described. Early results reported by Oermann et al in a retrospective study of 26 patients (median age, 41 years) at a median of 25 months' follow-up suggest that this approach can yield results comparable to those of frame-based methods. [22]

Surgical risk has commonly been determined by using the AVM grading system proposed by Spetzler and Martin. [23]  In this system, AVMs are graded from I through V by adding up the numerical values for the following three variables:

  • Size of nidus - Small (<3 cm), 1; medium (3-6 cm), 2; large (>6 cm), 3
  • Eloquence of adjacent brain - Noneloquent, 0; eloquent, 1
  • Venous drainage - Superficial only, 0; deep, 1

Grade VI lesions are essentially unresectable. A supplement to the Spetzler-Martin system has been described that adds up to five additional points for three more variables: age, unruptured presentation, and diffuseness. [24]

In 2011, Spetzler et al simplified the original Spezler-Martin grading into a three-tier system, by which grades I and II are combined into class A, grade III becomes class B, and grades IV and V are combined into class C. [25]

Previous
Next:

Complications

Complications that may occur after embolization/sclerotherapy or surgical excision include the following:

  • Expansion
  • Recurrence
  • Poor cosmesis, disfigurement
Previous
Next:

Diet and Activity

No special diet is required or recommended.

Activity is not limited unless the patient is undergoing an interventional or surgical procedure.

Previous
Next:

Consultations

As mentioned previously, the management of vascular anomalies requires interdisciplinary care and collaboration between many specialities. Specific consultations depend on the type of vascular anomaly and its location. With regard to AVMs in particular, possible consultations include the following:

  • Pediatric or general surgery
  • Plastic surgery
  • Vascular surgery
  • Neurosurgery
  • Otolaryngology
  • Orthopedic surgery
  • Radiology
  • Interventional radiology
  • Hematology
  • Gastroenterology
  • Physical therapy
  • Occupational therapy
  • Speech therapy
Previous
Next:

Long-Term Monitoring

The chance of recurrence after surgical resection of an AVM is high, and experienced surgeons recognize that long-term follow-up is critical to ensure a cure. [5, 1]  Accordingly, patients must be followed for years with regular physical examination, ultrasonography, MRI, or some combination thereof.

Previous